Mepolizumab improves small airway disease in severe eosinophilic asthmatics

被引：1
|
作者：
Cefaloni, Francesca [1 ]
Boccabella, Cristina [1 ]
Richeldi, Luca [2 ]
Bonini, Matteo [3 ,4 ]
机构：
[1] Univ Cattolica Sacro Cuore, Dept Cardiovasc & Pulm Sci, Rome, Italy
[2] Univ Cattolica Sacro Cuore, Dept Cardiovasc & Pulm Sci, Fdn Policlin Univ A Gemelli IRCCS, Dept Neurol ENT & Thorac Sci, Rome, Italy
[3] Univ Cattolica Sacro Cuore, Dept Cardiovasc & Pulm Sci, Fdn Policlin Univ A Gemelli IRCCS, Dept Neurol ENT & Thorac Sci,Natl Heart & Lung In, Rome, Italy
[4] Imperial Coll London, London, England
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA4093
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA4093
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
    Ortega, Hector G.
    Liu, Mark C.
    Pavord, Ian D.
    Brusselle, Guy G.
    FitzGerald, J. Mark
    Chetta, Alfredo
    Humbert, Marc
    Katz, Lynn E.
    Keene, Oliver N.
    Yancey, Steven W.
    Chanez, Pascal
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (13): : 1198 - 1207
  • [32] OUTCOMES WITH MEPOLIZUMAB AND BENRALIZUMAB IN SEVERE EOSINOPHILIC ASTHMA
    Elsey, L.
    Hince, K.
    Aspin, P.
    Pantin, C. T.
    Allen, D.
    Niven, R.
    Fowler, S. J.
    Tavernier, G.
    THORAX, 2021, 76 : A142 - A142
  • [33] Mepolizumab for the reduction of exacerbations in severe eosinophilic asthma
    Russell, Richard
    Brightling, Christopher
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (06) : 607 - 617
  • [34] Small airway impairment in moderate to severe asthmatics without significant proximal airway obstruction
    Perez, Thierry
    Chanez, Pascal
    Dusser, Daniel
    Devillier, Philippe
    RESPIRATORY MEDICINE, 2013, 107 (11) : 1667 - 1674
  • [35] Oscillometry in severe eosinophilic asthma commencing mepolizumab or benralizumab
    Fernando, M.
    Jeffrey, B.
    Tierney, C.
    Seccombe, L.
    Peters, M.
    Farah, C.
    Cottee, A.
    RESPIROLOGY, 2023, 28 : 81 - 81
  • [36] CLINICAL RESPONSE TO MEPOLIZUMAB IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA
    Harvey, E.
    Langton, D.
    Powell, H.
    Gibson, P.
    RESPIROLOGY, 2019, 24 : 42 - 42
  • [37] Benralizumab rapidly improves asthma control in Austrian real-life severe eosinophilic asthmatics
    Renner, Andreas
    Marth, Katharina
    Patocka, Karin
    Idzko, Marco
    Pohl, Wolfgang
    ALLERGY, 2020, 75 (12) : 3272 - 3275
  • [38] Clinical response to mepolizumab in patients with severe eosinophilic asthma
    Harvey, Erin
    Langton, David L.
    Powell, Heather
    Gibson, Peter G.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [39] Secondary loss of response to mepolizumab in severe eosinophilic asthma
    Cormier, Maxime
    Chaboillez, Simone
    Lemiere, Catherine
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (02): : 736 - 738
  • [40] Characterisation of a cohort of asthmatics with severe concordant eosinophilic disease according to their IgE status
    Gerday, Sara
    Schleich, Florence
    Henket, Monique
    Guissard, Francoise
    Paulus, Virginie
    Louis, Renaud
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
12345